Inhibition of apoptosis-specific elF-5A ("elF-5A1") with antisense oligonucleotides and siRNAs as antiinflammatory therapeutics

Details for Australian Patent Application No. 2004258070 (hide)

International Classifications

Event Publications

12 January 2006 PCT application entered the National Phase

PCT publication WO2005/007853 Priority application(s): WO2005/007853

30 March 2006 Amendment Made

The nature of the amendment is: Add co-inventors Cliche`, Dominic and Pomerantz, Benjamin

11 December 2008 Application Accepted

Published as AU-B-2004258070

9 April 2009 Standard Patent Sealed

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 March 2010 Section 223 Application Received

Senesco Technologies, Inc. An application to extend the time from 07 Jun 2009 to 07 Feb 2010 in which to pay a renewal fee has been filed . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

13 May 2010 Section 223 Application Allowed

Senesco Technologies, Inc. the time in which to pay a renewal fee has been extended to 07 Feb 2010. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.